Know Cancer

or
forgot password

    • cancer clinical trials in oregon

    • Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Kaiser Permanente

    Trial Locations
    Kaiser Permanente
    Legacy Good Samaritan Hospital and Medical Center
    Providence Saint Vincent Medical Center
    Columbia River Oncology Program
    Legacy Meridian Park Hospital
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct
    Clackamas Radiation Oncology Center

    Trial Locations
    Clackamas Radiation Oncology Center
    Providence Milwaukie Hospital
    Providence Newberg Medical Center
    Willamette Falls Hospital
    CCOP - Columbia River Oncology Program
    Providence Cancer Center at Providence Portland Medical Center
    Providence St. Vincent Medical Center
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer
    S0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung Cancer
    CCOP - Columbia River Oncology Program

    Trial Locations
    CCOP - Columbia River Oncology Program
    Providence Cancer Center at Providence Portland Medical Center
    Providence St. Vincent Medical Center
    Adventist Medical Center
    Lung Cancer
    Gene Transfer for Cancer Pain
    Pain Research of Oregon, LLC
    Eugene, Oregon 97401
    Cancer Pain
    Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
    Willamette Valley Cancer Center - Eugene

    Trial Locations
    Willamette Valley Cancer Center - Eugene
    Legacy Good Samaritan Hospital & Comprehensive Cancer Center
    Northwest Cancer Specialists at Rose Quarter Cancer Center
    Endometrial Cancer, Fatigue, Neurotoxicity
    Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma
    Clackamas Radiation Oncology Center

    Trial Locations
    Clackamas Radiation Oncology Center
    Providence Milwaukie Hospital
    Providence Newberg Medical Center
    Willamette Falls Hospital
    CCOP - Columbia River Oncology Program
    Knight Cancer Institute at Oregon Health and Science University
    Providence Cancer Center at Providence Portland Medical Center
    Providence St. Vincent Medical Center
    Legacy Good Samaritan Hospital & Comprehensive Cancer Center
    Lymphoma
    Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
    Adventist Medical Center
    Portland, Oregon 97216
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer
    Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Clackamas Radiation Oncology Center

    Trial Locations
    Clackamas Radiation Oncology Center
    Providence Milwaukie Hospital
    Providence Newberg Medical Center
    Willamette Falls Community Hospital
    Providence Portland Medical Center
    Oregon Health and Science University
    Providence Saint Vincent Medical Center
    Columbia River Oncology Program
    Salem Hospital
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer
    Pfizer Investigational Site
    Eugene, Oregon 97401
    Carcinoma, Renal Cell
    Broccoli Sprout Extract in Treating Women Who Have Had a Mammogram and Breast Biopsy
    Knight Cancer Institute at Oregon Health and Science University
    Portland, Oregon 97239-3098
    Breast Cancer, Precancerous Condition
    A Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin Lymphoma
    Oregon Health & Science University
    Portland, Oregon 97201
    Disease, Hodgkin
    Evaluating the Safety and Effectiveness of a Bone Marrow Transplant From Partially Matched Donors and Using Low Dose Chemotherapy in People With Leukemia or Lymphoma (BMT CTN #0603)
    Oregon Health & Science University
    Portland, Oregon 97201
    Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Burkitt Lymphoma, Lymphoma, B-Cell, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse
    Treatment With Pazopanib for Neoadjuvant Breast Cancer
    GSK Investigational Site
    Oregon City, Oregon 97045
    Neoplasms, Breast
    Efficacy and Safety of MORAb-003 in Subjects With Platinum-sensitive Ovarian Cancer in First Relapse
    Willamette Valley Cancer Center

    Trial Locations
    Willamette Valley Cancer Center
    Oregon Health & Science University
    Kaiser Permanente Northwest
    Providence Oncology & Hematology Care
    Ovarian Cancer
    S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
    Legacy Mount Hood Medical Center

    Trial Locations
    Legacy Mount Hood Medical Center
    Legacy Emanuel Hospital and Health Center and Children's Hospital
    Legacy Good Samaritan Hospital & Comprehensive Cancer Center
    Legacy Meridian Park Hospital
    Breast Cancer
    Acute Pain Caused by Paclitaxel in Patients With Cancer
    Willamette Falls Hospital

    Trial Locations
    Willamette Falls Hospital
    CCOP - Columbia River Oncology Program
    Providence Cancer Center at Providence Portland Medical Center
    Providence St. Vincent Medical Center
    Adventist Medical Center
    Chemotherapeutic Agent Toxicity, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific